The Health Department began offering pre-exposure prophylaxis (PREP) in our Sexual Health Center on October 14, 2019. This program is a daily pill used to lower the risk of contracting HIV. A combination of two HIV medicines (tenofovir and emtricitabine), sold under the name Truvada (pronounced Tru-va-duh), is approved for daily use. Daily use of this use can reduce the risk of contracting HIV from sex by more than 99%. Among people who inject drugs, this program reduces the risk of contracting HIV by more than 74%. The Metro Public Health Department’s Sexual Health Center’s Pre-Exposure Prophylaxis Clinic offers confidential testing, counseling services, and prescriptions for individuals at high-risk for exposure to HIV.
Learn more about the Pre-Exposure Prophylaxis Clinic
Related Images
